Musculoskeletal Manifestations of Thyroid Disease

Rheumatic Disease Clinics of North America

Volumn 36, Issue 4, 2010, Pages 637-646

  Anwar, Sabeen ^a   Gibofsky, Allan ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Arthritis; Endocrine; Thyroid

Indexed keywords

ALENDRONIC ACID; AUTOANTIBODY; CALCIUM; CALCIUM PYROPHOSPHATE; CORTICOSTEROID; THIAMAZOLE; VITAMIN D;

ARTHROPATHY; AUTOIMMUNE DISEASE; BONE METABOLISM; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MUSCULOSKELETAL DISEASE; MYOPATHY; MYXEDEMA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; THYROID DISEASE;

COMORBIDITY; FEMALE; HUMANS; MALE; MUSCULOSKELETAL DISEASES; THYROID DISEASES;

EID: 78449238461     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.09.001     Document Type: Review

References (78)

1. Aoki Y., Belin R.M., Clickner R., et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007, 17(12):1211-1223.
2. Tunbridge W.M., Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977, 7(6):481-493.
3. Vanderpump M.P., Tunbridge W.M., French J.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43(1):55-68.
4. Dorwart B.B., Schumacher H.R. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med 1975, 59(6):780-790.
5. Gordon T.P., Smith M., Ebert B., et al. Articular chondrocalcinosis in a hospital population: an Australian experience. Aust N Z J Med 1984, 14(5):655-659.
6. Komatireddy G.R., Ellman M.H., Brown N.L. Lack of association between hypothyroidism and chondrocalcinosis. J Rheumatol 1989, 16(6):807-808.
7. Job-Deslandre C., Menkes C.J., Guinot M., et al. Does hypothyroidism increase the prevalence of chondrocalcinosis?. Br J Rheumatol 1993, 32(3):197-198.
8. Jones A.C., Chuck A.J., Arie E.A., et al. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992, 22(3):188-202.
9. Doherty M., Chuck A., Hoskin D., et al. Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition. Arthritis Rheum 1991, 34(10):1297-1303.
10. Hartl E., Finsterer J., Grossegger C., et al. Relationship between thyroid function and skeletal muscle in subclinical and overt hypothyroidism. Endocrinologist 2001, 11:217-221.
11. Duyff R.F., Van den Bosch J., Laman D.M., et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatr 2000, 68(6):750-755.
12. Cruz M.W., Tendrich M., Vaisman M., et al. Electroneuromyography and neuromuscular findings in 16 primary hypothyroidism patients. Arq Neuropsiquiatr 1996, 54(1):12-18.
13. Mizusawa H., Takagi A., Nonaka I., et al. Muscular abnormalities in experimental hypothyroidism of rats with special reference to the mounding phenomenon. Exp Neurol 1984, 85(3):480-492.
14. Klein I., Parker M., Shebert R., et al. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med 1981, 70(4):891-894.
15. Tullu M.S., Udgirkar V.S., Muranjan M.N., et al. Kocher-Debre-Semelaigne syndrome: hypothyroidism with muscle pseudohypertrophy. Indian J Pediatr 2003, 70(8):671-673.
16. Spiro A.J., Hirano A., Beilin R.L., et al. Cretinism with muscular hypertrophy (Kocher-Debré-Sémélaigne syndrome). Histochemical and ultrastructural study of skeletal muscle. Arch Neurol 1970, 23(4):340-349.
17. Graig F.A., Ross G. Serum creatine-phosphokinase in thyroid disease. Metabolism 1963, 12:57-59.
18. Griffiths P.D. Serum enzymes in diseases of the thyroid gland. J Clin Pathol 1965, 18(5):660-663.
19. Giampietro O., Clerico A., Buzzigoli G., et al. Detection of hypothyroid myopathy by measurement of various serum muscle markers-myoglobin, creatine kinase, lactate dehydrogenase and their isoenzymes. Correlations with thyroid hormone levels (free and total) and clinical usefulness. Horm Res 1984, 19(4):232-242.
20. Madariaga M.G. Polymyositis-like syndrome in hypothyroidism: review of cases reported over the past twenty-five years. Thyroid 2002, 12(4):331-336.
21. Scott K.R., Simmons Z., Boyer P.J. Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle Nerve 2002, 26(1):141-144.
22. McKeran R.O., Ward P., Slavin G., et al. Central nuclear counts in muscle fibres before and during treatment in hypothyroid myopathy. J Clin Pathol 1979, 32(3):229-233.
23. Scarpalezos S., Lygidakis C., Papageorgiou C., et al. Neural and muscular manifestations of hypothyroidism. Arch Neurol 1973, 29(3):140-144.
24. Klein I., Levey G.S. Unusual manifestations of hypothyroidism [review]. Arch Intern Med 1984, 144(1):123-128.
25. Norris F.H., Panner B.J. Hypothyroid myopathy. Clinical, electromyographical, and ultrastructural observations. Arch Neurol 1966, 14(6):574-589.
26. Khaleeli A.A., Griffith D.G., Edwards R.H. The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin Endocrinol (Oxf) 1983, 19(3):365-376.
27. Evans R.M., Watanabe I., Singer P.A. Central changes in hypothyroid myopathy: a case report. Muscle Nerve 1990, 13(10):952-956.
28. Ono S., Inouye K., Mannen T. Myopathology of hypothyroid myopathy. Some new observations. J Neurol Sci 1987, 77(2-3):237-248.
29. Mastaglia F.L., Ojeda V.J., Sarnat H.B., et al. Myopathies associated with hypothyroidism: a review based upon 13 cases. Aust N Z J Med 1988, 18(6):799-806.
30. Caiozzo V.J., Baker M.J., Baldwin K.M. Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading. J Appl Physiol 1998, 85(6):2237-2248.
31. Atroshi I., Gummesson C., Johnsson R., et al. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999, 282(2):153-158.
32. van Dijk M.A., Reitsma J.B., Fischer J.C., et al. Indications for requesting laboratory tests for concurrent diseases in patients with carpal tunnel syndrome: a systematic review. Clin Chem 2003, 49(9):1437-1444.
33. Katz J.N., Larson M.G., Sabra A., et al. The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med 1990, 112(5):321-327.
34. Chisholm J.C. Hypothyroidism: a rare cause of the bilateral carpal tunnel syndrome-a case report and a review of the literature. J Natl Med Assoc 1981, 73(11):1082-1085.
35. Purnell D.C., Daly D.D., Lipscomb P.R. Carpal-tunnel syndrome associated with myxedema. Arch Intern Med 1961, 108:751-756.
36. Kececi H., Degirmenci Y. Hormone replacement therapy in hypothyroidism and nerve conduction study. Neurophysiol Clin 2006, 36(2):79-83.
37. Palumbo C.F., Szabo R.M., Olmsted S.L. The effects of hypothyroidism and thyroid replacement on the development of carpal tunnel syndrome. J Hand Surg Am 2000, 25(4):734-739.
38. Ramsay I.D. Muscle dysfunction in hyperthyroidism. Lancet 1966, 2(7470):931-934.
39. Fatourechi V., Pajouhi M., Fransway A.F. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 1994, 73(1):1-7.
40. Kriss J.P. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987, 16(2):409-415.
41. Schwartz K.M., Fatourechi V., Ahmed D.D., et al. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002, 87(2):438-446.
42. Komosińska-Vassev K., Winsz-Szczotka K., Olczyk K., et al. Alterations in serum glycosaminoglycan profiles in Graves' patients. Clin Chem Lab Med 2006, 44(5):582-588.
43. Heufelder A.E., Bahn R.S., Scriba P.C. Analysis of T cell antigen receptor variable region gene usage in patients with thyroid-related pretibial dermopathy. J Invest Dermatol 1995, 105(3):372-378.
44. Nixon D.W., Samols E. Acral changes in thyroid disorders. N Engl J Med 1971, 284(20):1158-1159.
45. Fatourechi V., Ahmed D.D., Schwartz K.M. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab 2002, 87(12):5435-5441.
46. Mosekilde L., Melsen F. A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand 1978, 204(1-2):97-102.
47. Britto J.M., Fenton A.J., Holloway W.R., et al. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994, 134(1):169-176.
48. Daly J.G., Greenwood R.M., Himsworth R.L. Serum calcium concentration in hyperthyroidism at diagnosis and after treatment. Clin Endocrinol (Oxf) 1983, 19(3):397-404.
49. Toh S.H., Claunch B.C., Brown P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985, 145(5):883-886.
50. Fraser S.A., Anderson J.B., Smith D.A., et al. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971, 1(7707):981-983.
51. Jódar E., Muñoz-Torres M., Escobar-Jiménez F., et al. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause. Clin Endocrinol (Oxf) 1997, 47(3):279-285.
52. Rosen C.J., Adler R.A. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 1992, 75(6):1531-1534.
53. Vestergaard P., Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis. Thyroid 2003, 13(6):585-593.
54. Lupoli G., Nuzzo V., Di Carlo C., et al. Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. Gynecol Endocrinol 1996, 10(5):343-348.
55. Laurent E., Mockel J., Van Sande J., et al. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol 1987, 52(3):273-278.
56. Pyne D., Isenberg D.A. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002, 61(1):70-72.
57. Morita S., Arima T., Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metab 1995, 80(4):1203-1206.
58. Spence D., Hornberger L., Hamilton R., et al. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies. J Rheumatol 2006, 33(1):167-170.
59. Boelaert K., Newby P.R., Simmonds M.J., et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010, 123(2):183. e1-9.
60. Namjou B., Kelly J.A., Kilpatrick J., et al. Linkage at 5q14.3-15 in multiplex systemic lupus erythematosus pedigrees stratified by autoimmune thyroid disease. Arthritis Rheum 2005, 52(11):3646-3650.
61. Magnus J.H., Birketvedt T., Haga H.J. A prospective evaluation of antithyroid antibody prevalence in 100 patients with rheumatoid arthritis. Scand J Rheumatol 1995, 24(3):180-182.
62. Atzeni F., Doria A., Ghirardello A., et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity 2008, 41(1):111-115.
63. Shiroky J.B., Cohen M., Ballachey M.L., et al. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993, 52(6):454-456.
64. Przygodzka M., Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Pol Arch Med Wewn 2009, 119(1-2):39-43.
65. Raterman H.G., Van Halm V.P., Voskuyl A.E., et al. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. Ann Rheum Dis 2008, 67(2):229-232.
66. Antonelli A., Delle Sedie A., Fallahi P., et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol 2006, 33(10):2026-2028.
67. Zeher M., Horvath I.F., Szanto A., et al. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome. Thyroid 2009, 19(1):39-45.
68. Lazarus M.N., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome. Ann Rheum Dis 2005, 64(7):1062-1064.
69. Hansen B.U., Ericsson U.B., Henricsson V., et al. Autoimmune thyroiditis and primary Sjögren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 1991, 9(2):137-141.
70. Harel L., Prais D., Uziel Y., et al. Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol 2006, 33(1):164-166.
71. Kahl L.E., Medsger T.A., Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 1986, 13(1):103-107.
72. Hämeenkorpi R., Hakala M., Ruuska P., et al. Thyroid disorder in patients with mixed connective tissue disease. J Rheumatol 1993, 20(3):602-603.
73. Bowness P., Shotliff K., Middlemiss A., et al. Prevalence of hypothyroidism in patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1991, 30(5):349-351.
74. Wiseman P., Stewart K., Rai G.S. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis. BMJ 1989, 298(6674):647-648.
75. Barrier J.H., Abram M., Brisseau J.M., et al. Autoimmune thyroid disease, thyroid antibodies and giant cell arteritis: the supposed correlation appears fortuitous. J Rheumatol 1992, 19(11):1733-1734.
76. Dasgupta B., Grundy E., Stainer E. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis: lack of any association. BMJ 1990, 301(6743):96-97.
77. Pamuk O.N., Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 2007, 26(1):55-59.
78. Neeck G., Riedel W. Thyroid function in patients with fibromyalgia syndrome. J Rheumatol 1992, 19(7):1120-1122.